Open AccessMETA-ANALYSIS EVALUATING THE RISK OF ATRIAL FIBRILLATION WITH NEWER ANTIDIABETICS ACROSS THE CARDIOVASCULAR AND RENAL OUTCOME TRIALS
Author(s) -
Dimitrios Patoulias,
Maria Toumpourleka,
Alexandra Katsimardou,
Κonstantinos Imprialos,
Konstantinos Stavropoulos,
Konstantinos Koutsampasopoulos,
Maria Mavridou,
Fotios Siskos,
Christodoulos Papadopoulos,
Michael Doumas
Publication year - 2021
Publication title -
journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.249
H-Index - 172
eISSN - 1473-5598
pISSN - 0263-6352
DOI - 10.1097/01.hjh.0000745428.72000.19
Subject(s) - medicine , placebo , atrial fibrillation , heart failure , diabetes mellitus , glycemic , clinical trial , relative risk , type 2 diabetes mellitus , cardiology , endocrinology , insulin , confidence interval , alternative medicine , pathology